Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana ...
Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...
The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...
Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for PT-141 peptide reference material, provided strictly for laboratory developmental ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
At Pittcon 2026, LCGC International Emerging Leader Award Winner, Bob Pirok, discussed the barriers to fully automated method development using machine learning in chromatography and if "intuition" ...
Chinese hamster ovary (CHO) cells are being pushed to their productivity limits in drug development and manufacturing. Biopharmaceutical companies working on promising new therapies increasingly ...
Mississippi will invest over $100 million in economic development, infrastructure, and workforce training across the state. The funding comes from multiple sources, including the Mississippi ...
The Center for Clinical and Translational Science (CCTS) is pleased to announce the latest recipients of CCTS Statistical and Analytic Methods Development support. This competitive program is designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results